Insider trades
Lynn Seely, CEO of Lyell Immunopharma LYEL, has filed 1 purchase and 7 sales on the open market. Over the past 12 months that comes to a net sale of $198.5K. The latest trade was on 05/11.
Lynn Seely
President and CEO
- Company
- Lyell Immunopharma LYEL
- First filing
- 23/06/23
- Trades
- 35 trades
- Buys / sales
- 1 / 7
- 12-month net buying
- −$198.5K
- Last trade
- 05/11
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 05/11 | 06/15 | 388 sh | $18.91 | $7,337.08 | −0.5% | |
| Open-market sale | 02/11 | 02/12 | 7,455 sh | $23.39 | $174,372.45 | −9.1% | |
| Open-market sale | 02/10 | 02/11 | 438 sh | $23.12 | $10,126.56 | −0.5% | |
| Open-market sale | 25/11/10 | 25/11/12 | 412 sh | $16.11 | $6,637.32 | −0.6% | |
| Open-market sale | 25/08/21 | 25/08/22 | 7,257 sh | $10.54 | $76,488.78 | −9.7% | |
LYEL | Open-market sale | 25/08/11–25/08/12 | 25/08/13 | 797 sh2 trades | $10.43avg. | $8,315.27 | −2.2% |
| Open-market buy | 25/03/14 | 25/03/18 | 175,000 sh | $0.61 | $106,750 | +32.6% |